Image

Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer

Testing carbon ion treatment for certain lung cancer to improve outcomes.

Recruiting
18-80 years
All
Phase 2
This study wants to see if a new way of giving radiation called **carbon ion radiotherapy** can help patients with a type of lung cancer called **non-small cell lung cancer (NSCLC)** that can't be removed by surgery. In this study, patients will get radiation to their whole tumor, but one group will get extra radiation to a special part of the tumor that doesn't get enough oxygen (called **hypoxic lesions**). These areas are found using a special scan called **18F-Misonidazole PET/CT**. The study will compare how long the cancer stays away and other health outcomes between the two groups. **Key Points**: - The study will last for a specific treatment period with follow-up visits afterward. - Participants need to have specific health conditions and must **sign a consent form**. - There are possible side effects and risks related to radiation therapy that will be monitored. **Eligibility**: Adults aged 18-80 with certain lung cancer conditions can join. People with other severe health issues, certain past treatments, or who are pregnant cannot participate.
Study details
    Non-small Cell Lung Cancer

NCT06205927

Jian Chen

24 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.